Hardayal Pharma Distributors Private Limited
Manufactures and trades medical and pharmaceutical products since 1995.
1995 | Thane, Maharashtra (India) | Active
Hardayal Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.40 M
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.40 M
About Hardayal Pharma Distributors
Hardayal Pharma Distributors Private Limited (HPDPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 1995 and has a history of 29 years and 11 months. Its registered office is in Thane, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹0.40 M.
Ashok Tolani, Bhavika Ailani, Mamata Tolani, and One other member serve as directors at the Company.
Company Details
- Location Thane, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397MH1995PTC086829
- Company No.
086829
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Hardayal Pharma Distributors?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Tolani  | Director | 24-Mar-1995 | Current |
| Bhavika Ailani | Director | 24-Feb-2024 | Current |
| Mamata Tolani | Director | 15-Mar-1999 | Current |
| Haresh Tolani | Director | 24-Mar-1995 | Current |
Financial Performance of Hardayal Pharma Distributors.
Hardayal Pharma Distributors Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hardayal Pharma Distributors?
In 2017, Hardayal Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0.40 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Apr 1997 | Union Bank Of India | ₹0.40 M | Open |
How Many Employees Work at Hardayal Pharma Distributors?
Unlock and access historical data on people associated with Hardayal Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hardayal Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hardayal Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
